ConductScience.org, home

Paper11041571

Myopericarditis caused by cyclophosphamide used to mobilize peripheral blood stem cells in a myeloma patient with renal failure.

Yamamoto R and 15 others. Bone Marrow Transplant, 2000. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Myopericarditis caused by cyclophosphamide used to mobilize peripheral blood stem cells in a myeloma patient with renal failure. Papers, record 11041571. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11041571

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Myopericarditis caused by cyclophosphamide used to mobilize peripheral blood stem cells in a myeloma patient with renal failure.
PubMed
Journal
Bone Marrow Transplant
PubMed
Year
2000
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.31
iCite
Revised in PubMed
2026-10-10
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yamamoto RR
2Kanda YY
3Matsuyama TT
4Oshima KK
5Nannya YY
6Suguro MM
7Chizuka AA
8Hamaki TT
9Takezako NN
10Miwa AA
11Kami MM
12Mori SS
13Kojima TT
14Saito KK
15Itaoka YY
16Kashida MM

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Agents, AlkylatingMajor topic
CyclophosphamideMajor topic
Hematopoietic Stem Cell MobilizationMajor topic
MyocarditisMajor topic
PericarditisMajor topic
Renal InsufficiencyMajor topic
Adult
Female
Humans
Multiple Myeloma
Pericardial Effusion

Source PubMed

Download CSV of topics

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17437246Repeated investigations of cyclophosphamide disposition in myeloma patients receiving intermittent chemotherapy.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7437246PubMed
28857936Progenitor cell yield in sequential blood stem cell mobilization in the same patients: insights into chemotherapy dose escalation and combination of haemopoietic growth factor and chemotherapy.Br J Haematol1996https://conductscience.org/library/papers/8857936PubMed
39552064Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma.J Clin Oncol1998https://conductscience.org/library/papers/9552064PubMed
41277189The effect of allopurinol on cyclophosphamide antitumor activity.Cancer Res1976https://conductscience.org/library/papers/1277189PubMed
56432305Therapeutic effects of single-push or fractionated injections or continuous infusion of oxazaphosphorines (cyclophosphamide, ifosfamide, Asta Z 7557).Cancer1984https://conductscience.org/library/papers/6432305PubMed
6535136The disposition of cyclophosphamide in a group of myeloma patients.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/535136PubMed
76546971Effective treatment of advanced multiple myeloma refractory to alkylating agents.N Engl J Med1984https://conductscience.org/library/papers/6546971PubMed
87235784Cardiotoxicity associated with high-dose cyclophosphamide therapy.Arch Intern Med1981https://conductscience.org/library/papers/7235784PubMed
92025981Clinical pharmacokinetics of cyclophosphamide.Clin Pharmacokinet1991https://conductscience.org/library/papers/2025981PubMed
109383228High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency.Bone Marrow Transplant1997https://conductscience.org/library/papers/9383228PubMed
119232259Peripheral blood stem cell transplantation in a multiple myeloma patient with end-stage renal failure.Bone Marrow Transplant1997https://conductscience.org/library/papers/9232259PubMed
128289856The treatment of multiple myeloma.N Engl J Med1994https://conductscience.org/library/papers/8289856PubMed
138649495A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.N Engl J Med1996https://conductscience.org/library/papers/8649495PubMed
144398496Marrow transplanation in man following cyclophosphamide.Transplant Proc1971https://conductscience.org/library/papers/4398496PubMed
156697291High-dose cyclophosphamide. An effective treatment for advanced refractory multiple myeloma.Cancer1984https://conductscience.org/library/papers/6697291PubMed
163533179Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor.Blood1986https://conductscience.org/library/papers/3533179PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
40861688Pericardial Calcification Following Acute Myopericarditis After Initial CHOP Treatment for Mantle Cell Lymphoma: A Case Report.Cureus2025https://conductscience.org/library/papers/40861688PubMed
31768769Cancer Treatment-Associated Pericardial Disease: Epidemiology, Clinical Presentation, Diagnosis, and Management.Curr Cardiol Rep2019https://conductscience.org/library/papers/31768769PubMed
29936603Pericardial Disease in Cancer Patients.Curr Treat Options Cardiovasc Med2018https://conductscience.org/library/papers/29936603PubMed
25239940
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
Eur Heart J Cardiovasc Imaging2014https://conductscience.org/library/papers/25239940PubMed
21358693Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA.Bone Marrow Transplant2012https://conductscience.org/library/papers/21358693PubMed
18548196Cardiac toxicity of high-dose cyclophosphamide and melphalan in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation.Int J Hematol2008https://conductscience.org/library/papers/18548196PubMed
17237828Marrow transplantation for severe aplastic anemia with significant renal impairment.Bone Marrow Transplant2007https://conductscience.org/library/papers/17237828PubMed
12189539Successful allogeneic blood stem cell transplantation for aplastic anemia in a patient with renal insufficiency requiring dialysis.Bone Marrow Transplant2002https://conductscience.org/library/papers/12189539PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11041571

GET https://conductscience.org/api/papers/v1/11041571/authors